Nolvadex (Tamoxifen Citrate)

Tamoxifen citrate binds to estrogen receptors in breast tissue, acting as an antagonist that blocks estrogen‑driven cell growth. In other tissues, such as bone, it can act as a partial agonist, providing a balanced hormonal effect while inhibiting tumor proliferation.

The specific dose of Nolvadex is determined by the prescribing clinician based on the individual’s condition, treatment stage, and overall health. Typical regimens are individualized, and patients should follow the dosage instructions provided by their healthcare professional.

Nolvadex is classified as Pregnancy Category D, indicating evidence of fetal risk, and it is contraindicated during pregnancy. It is also not recommended for breastfeeding mothers because it can pass into breast milk and affect the infant.

To order Nolvadex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The primary alternative to Nolvadex is the class of aromatase inhibitors, which lower estrogen production rather than block its receptor. While aromatase inhibitors are often used after menopause, Nolvadex can be effective in pre‑menopausal patients and offers a different side‑effect profile, such as fewer bone‑density concerns but a higher risk of thromboembolic events.

Nolvadex tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Nolvadex is taken orally as a tablet, with or without food, according to the prescribing physician’s instructions. Swallow the tablet whole with a glass of water and do not crush or chew it unless directed otherwise.

Serious risks include deep vein thrombosis or pulmonary embolism, endometrial cancer, severe liver injury, and allergic reactions such as rash or swelling. Patients should promptly report unexplained leg pain, shortness of breath, abnormal uterine bleeding, jaundice, or any signs of an allergic response.

Nolvadex should not be used by pregnant women, individuals with known hypersensitivity to tamoxifen or its excipients, patients with a history of thromboembolic disorders, or those with active liver disease without close monitoring. Clinicians must evaluate each patient’s medical history before initiating therapy.